Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Royal Philips reported third-quarter earnings above expectations, supported by new AI-powered medical tools and actions to offset tariff impacts. The company recorded €531 million in adjusted EBITA and a 3% increase in sales, led by strong North American performance.
Hippocratic AI has secured $126 million in Series C funding led by Avenir Growth, valuing the company at $3.5 billion. The funds will support expansion, product development, and international growth for its generative AI healthcare agents.
Dr. Aaron Cohen-Gadol, recipient of the Vilhelm Magnus Medal, has introduced ATLAS GPT, an agentic AI platform designed to support clinical decision-making across 35 medical specialties.
AmacaThera has entered into an exclusive global licensing agreement with Pacira BioSciences worth up to $230 million to develop AMT-143, a long-acting non-opioid anesthetic for post-operative pain. Pacira will fund clinical development, manufacturing, and commercialization, with Phase 2 trials expected to start in 2026.
Subtle Medical has received EU MDR CE Marking and entered the UK market, making its AI-powered MRI enhancement software SubtleHD commercially available across the region.
SOPHiA GENETICS reported third-quarter 2025 revenue of $19.5 million, a 23% increase year-over-year, and raised its full-year revenue guidance to between $75 million and $77 million. The company highlighted strong adoption of its SOPHiA DDM platform and expanded partnerships in precision medicine.
Recor Medical and Otsuka Medical Devices announced clinical data showing a 19.6 mmHg blood pressure reduction after six months using the Paradise renal denervation system, presented at the TCT 2025 conference.
A new survey by EY US and KLAS Research shows that most healthcare organizations now view cybersecurity as a core business priority, with 81% integrating it into strategic operations and 72% reporting recent financial impacts from cyber incidents.
STEMup Science and Technology Institute and Connexis Search Group have formed a national partnership to enhance workforce readiness and leadership development across the life sciences and technology sectors.
OpenAI CEO Sam Altman is reportedly backing Merge Labs, a brain-computer interface venture exploring ultrasound-based methods to interpret brain activity without surgery. The startup has recruited Caltech engineer Mikhail Shapiro and aims to raise $250 million at an $850 million valuation.
Archy has raised $20 million in Series B funding led by TCV, with participation from Bessemer Venture Partners, CRV, Entrée Capital, and 25 dentists. The company plans to use the funding to expand its AI-driven platform that automates scheduling, billing, and insurance for dental practices.
Remedy Robotics has introduced the Remedy N1 System, an AI-driven robotic platform that enables fully remote endovascular procedures. The company reported successful completion of the world’s first in-human remote neurointerventional operations between two Toronto hospitals.
Remedy Robotics has been named the exclusive robotics partner of Mission Thrombectomy to expand access to endovascular thrombectomy for stroke treatment using its N1 System in the U.S. and globally.
Monteris Medical and Symphony Robotics have announced a collaboration to develop an AI-driven micro-robotic system for laser ablation in the brain. The partnership aims to improve precision in MRI-guided neurosurgical procedures and enable minimally invasive treatment of complex brain tumors.
Healinno Tech and Beijing University of Posts and Telecommunications presented an ultrasound-guided hybrid robot for transperineal prostate biopsy at IROS 2025 in Hangzhou, China. The system uses a serial-parallel mechanism and a new optimization algorithm to enhance precision and control in clinical procedures.
ExaCare AI has raised $30 million in a Series A round led by Insight Partners to scale its AI platform for skilled nursing facilities and launch a suite of AI agents aimed at streamlining admissions and care operations.
Harbour BioMed has introduced its first fully human Generative AI HCAb Model, designed to accelerate biologics discovery through AI-driven antibody generation and validation, as announced in a press release.
MCG Health and Allegheny Health Network will discuss how AI can enhance evidence-based care and reduce denials at the 2025 ACMA Leadership & Physician Advisor Conference in Boston.
CareSet has appointed Sepideh Naseri as its first Chief Data and Analytics Officer to oversee data science, engineering, and analytics operations across its Medicare and Medicaid claims data services.
ID.me and Flexpa have announced a partnership to improve patient access to medical records, reduce AI-driven fraud, and support the CMS framework for healthcare interoperability.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
